Loading clinical trials...

RECRUITING

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy - CHOLINET (CHOLesterol Italian Inclisiran NETwork)

NCT06287177•Federico II University

View on ClinicalTrials.gov

Summary

Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life Italian population

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients under Inclisiran treatment

Exclusion Criteria

•Age \< 18 years o \> 80 years
•Patients who refuse to participate and to sign informed consent

Locations (1)

Federico II University of Naples, Department of Advanced Biomedical Sciences

Naples, Italy

Key Dates

Start Date

November 1, 2022

Primary Completion Date

February 29, 2024

Completion Date

November 1, 2030

Last Updated

January 22, 2026

Enrollment

3,000

ESTIMATED participants

Conditions

Hypercholesterolemia

Interventions

Inclisiran

DRUG

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

NCT07058077

Heterozygous Familial Hypercholesterolemia (HeFH)

View study

RECRUITINGNA

Screening for Familial Hypercholesterolemia in Children

NCT06555120

Hypercholesterolemia, Familial

View study

RECRUITING

Causes and Natural History of Dyslipidemias

NCT00353782

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 22, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy

Inclusion Criteria

Exclusion Criteria

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

Screening for Familial Hypercholesterolemia in Children

Causes and Natural History of Dyslipidemias

Pharmacokinetics of Butyrate Tablet BKR-017

A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib

The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository